BIOTRICITY INC. (BTCY)

Every figure this model derived for BTCY, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2022-03-31
cash 466,503 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 5,596,042 AssetsCurrent 2026-06-30
current liabilities 37,342,570 LiabilitiesCurrent 2026-06-30
equity -35,406,860 StockholdersEquity 2026-06-30
interest expense 3,363,449 InterestExpenseNonoperating 2026-06-30
ocf 161,661 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 16,401,202 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 359,667 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BTCY on one particular measure came for.

RatioValue
cash operating margin11.79
current ratio0.15
current ratio reported0.15
dilution pct26.87
fcf margin0.99
growth cv1.02
interest cover0.47
net debt ebitda6.68
operating margin9.56
owner earnings margin-1.21
revenue growth13.4
revenue growth per share-10.61
rule of 4022.96
sbc pct revenue2.19

What to be careful about

What this model itself distrusts about BTCY's figures. Written by the derivation as it ran, not added afterwards.